Vanda Pharmaceuticals Presentation at 2026 Eadv - Oct 2

The Story

Vanda Pharmaceuticals Inc. will present at the European Academy of Dermatology and Venereology Annual Meeting in Vienna, which runs from Sept. 30 through Oct. 3, 2026. The company, listed as $VNDA on Nasdaq, announced participation and said it will share data at the conference.

Why It Matters For Your Portfolio

• Event timing: The EADV meeting runs Sept. 30 through Oct. 3, 2026, creating a near-term window for potential stock-moving data tied to $VNDA.
• Valuation inputs: Available data points include 3.16%, 1.57% and 0.16%, figures analysts can incorporate into models when revaluing the company.
• Catalyst calendar: Company-listed upcoming catalysts include the BYSANTI program, which investors have highlighted as a potential driver of sentiment and trading activity.
• Multiple data points are now public, giving investors more inputs for scenario analysis and sensitivity testing rather than a single headline to trade on.

The Trade

This is a news-for-data event, so traders and event-driven investors will likely pay closest attention, while longer-term holders may want to use released data to update valuation assumptions. Watch for the company presentations and any follow-up summaries or slides posted after the EADV sessions, and monitor how market reaction aligns with the 3.16%, 1.57% and 0.16% metrics in your models.